Growth Metrics

Orthopediatrics (KIDS) Receivables - Other (2019 - 2025)

Orthopediatrics (KIDS) has disclosed Receivables - Other for 7 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Other changed 0.0% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 0.0% change, with the full-year FY2025 number at $1.2 million, changed 0.0% from a year prior.
  • Receivables - Other was $1.2 million for Q4 2025 at Orthopediatrics, roughly flat from $1.2 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.2 million in Q2 2021 to a low of $1.2 million in Q2 2021.
  • A 5-year average of $1.2 million and a median of $1.2 million in 2021 define the central range for Receivables - Other.
  • Biggest YoY gain for Receivables - Other was 0.0% in 2021; the steepest drop was 0.0% in 2021.
  • Orthopediatrics' Receivables - Other stood at $1.2 million in 2021, then changed by 0.0% to $1.2 million in 2022, then changed by 0.0% to $1.2 million in 2023, then changed by 0.0% to $1.2 million in 2024, then changed by 0.0% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Receivables - Other are $1.2 million (Q4 2025), $1.2 million (Q4 2024), and $1.2 million (Q4 2023).